Rhinitis News and Research

RSS

Rhinitis, commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of rhinitis is nasal dripping. It is caused by chronic or acute inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants.

Allergic rhinitis diagnosis and treatment: new guidelines for primary care professionals

Two complementary guidelines on the diagnosis and treatment of allergic rhinitis are published in the August issue of the Allergy journal.

24 Jul 2008

Australian scientists discover reason for extreme allergic reactions

Australian scientists believe they have discovered why some people experience extreme allergic reactions and their find could lead to new treatments for what seems to be an increasingly common problem.

1 Jul 2008

World Allergy report calls for urgent worldwide collaboration to tackle global increase in allergies

The World Allergy Organization (WAO) will publish its first Report on the extent of allergy and chronic respiratory diseases worldwide on the 18 June 2008 and has called for immediate collaboration to tackle the current escalation in allergy cases.

17 Jun 2008

New hay fever jab promises year long relief for sufferers

Relief is in sight for millions of hay fever sufferers with the promise of a jab, which lasts for a year, that significantly reduces symptoms.

15 May 2008

New discoveries in hearing health

Three studies published in the May 2008 edition of Otolaryngology - Head and Neck Surgery reveal substantial new findings in several areas of hearing health, including research that indicates that patients with profound hearing loss benefit substantially from having cochlear implants placed in both ears, rather than one, as is the common practice.

1 May 2008

ISTA Pharmaceuticals announces new clinical findings to support Bepreve NDA

ISTA Pharmaceuticals, Inc. has announced positive results from the preliminary analysis of its second and final Bepreve (bepotastine ophthalmic solution) Phase III clinical study.

30 Apr 2008

Mould in the home

Surely your bathroom is fungus-free once you've wiped the mould off the tiles? Not according to a study by French scientists in the Royal Society of Chemistry's Journal of Environmental Monitoring. They report that almost one in five rooms studied with no visible mould was in fact "highly contaminated" by fungus which could aggravate conditions such as asthma.

30 Apr 2008

Doctors should consider alternatives to antibiotics for sinusitis

When suffering through a sinus infection, many people ask for an antibiotic to speed their recovery. However, a recent review of clinical trials found that while antibiotics can provide minor improvements in uncomplicated sinusitis cases, most patients recover without the drugs within two weeks.

24 Apr 2008

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

16 Apr 2008

Childhood allergies interfere with sleep

New research suggests that while allergies can make children unwell during the daytime they often also interfere with their sleep.

17 Mar 2008

Nasal polyps from analgesics

If a patient develops respiratory problems after taking analgesics, this indicates that the active substances are poorly tolerated.

11 Mar 2008

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.

20 Feb 2008

Allergies linked to irritable bowel syndrome

Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published on January in Annals of Allergy, Asthma & Immunology, the scientific journal of the American Collegeof Allergy, Asthma and Immunology.

31 Jan 2008

Immunotherapy - How does immunotherapy work? When is immunotherapy helpful?

Those who suffer from allergic asthma, rhinitis, conjunctivitis or stinging insect allergies may be good candidates to receive immunotherapy, also known as "allergy shots," according to the American Academy of Allergy, Asthma & Immunology (AAAAI).

10 Jan 2008

Eczema still on the increase in developing countries

Experts are warning policy makers that allergic disease might replace infectious disease as a major cause of ill health in cities undergoing rapid demographic changes in developing countries.

7 Jan 2008

Saline irrigation versus saline spray for relief of chronic nasal symptoms

An inexpensive, safe and easy treatment is an effective method for treating chronic nasal and sinus symptoms – more effective, in fact, than commonly used saline sprays, according to a new study from University of Michigan Health System researchers.

20 Nov 2007

Relief for seasonal allergic rhinitis sufferers

The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.

29 Oct 2007

Prebiotics in infants for prevention of allergic disease and food hypersensitivity

Many parents add prebiotics and probiotics to children's food to help treat health problems, and according to two new reviews, the supplements might also help prevent eczema in babies at high risk.

17 Oct 2007

Economic development linked to differences in rates of asthma symptoms

Children with allergic sensitizations in economically developed countries are much more likely to develop asthma than similarly sensitized children in poorer countries, according to a team of international researchers.

17 Sep 2007

Ranbaxy receives tentative FDA approval for Fexofenadine hydrochloride tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market the antihistamine Fexofenadine Hydrochloride Tablets, 30 mg, 60 mg, and 180 mg.

18 May 2007